SDGR — Schrodinger Inc. stock price and chart

SDGR

$23.40+1.21%

as of close, Oct 20, 2026

☾ AH $23.40 +1.21%

Schrodinger Inc.Stock · HealthcareRussell 2000 · 0.03% of IWMUS Stock Market · 0.001% of VTIRussell 3000 · 0.001% of IWV

PeersBTSGSPYQQQNVDAAAPLMSFT

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Feb 11, 2020

VolumeEEEEEEEEEEEE

20202021202320252026

20.030.040.050.060.070.080.090.0100.0110.0010.0M20.0M$23.40

2026-10-20

Price$23.40

MA20$21.13

MA50$16.45

Vol1.4M

What would $1,000 invested in SDGR be worth today? →

SDGR returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $23.40
YTD price return: +30.87%
YTD total return: +30.87%
Next earnings: Nov 4, 2026
Market cap: 1.8B2020-03 2.2B2026-10 1.8B-19.0% over the window
Enterprise value: 1.4B
Shares outstanding: 74.8M2019-12 6.1M2026-06 74.8M+1122.0% over the window
52W low: $10.95
52W high: $33.78
From 52W high: -30.73%
From 52W low: +113.80%
52W range: 55%

Volume

Rel volume: 0.49×
30D volume: 2.8M
30D $ vol: 79.1M

Fundamentals

Sales (ttm): 259M2019-12 85.5M2026-06 259M+202.8% over the window
Sales/share: $3.462019-12 $13.972026-06 $3.46-75.2% over the window
EPS (ttm): -$0.732020-12 -$0.412026-06 -$0.73+78.5% over the window
FCF (ttm): -130.3M2019-12 -27.9M2026-06 -130.3M+367.0% over the window
FCF/share: -$1.742019-12 -$4.562026-06 -$1.74-61.8% over the window
Book value/share: $4.402019-12 -$15.252026-06 $4.40-128.8% over the window
Net margin: -20.98%2019-12 -28.7%2026-06 -21.0%-27.0% over the window
ROE: -16.52%2020-12 -3.9%2026-06 -16.5%+321.3% over the window
ROA: -8.48%2019-12 -15.8%2026-06 -8.5%-46.4% over the window
Current ratio: 2.712019-12 2.632026-06 2.71+2.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.88%2025-06-30 → 2026-06-30237.9M → 259M (+8.9% total)+10.15%2023-06-30 → 2026-06-30193.8M → 259M (+33.7% total)+16.50%2021-06-30 → 2026-06-30120.7M → 259M (+114.5% total)n/a
Shares: +1.88%2025-06-30 → 2026-06-3073.4M → 74.8M (+1.9% total)-0.11%2023-06-30 → 2026-06-3075.1M → 74.8M (-0.3% total)+3.98%2021-06-30 → 2026-06-3061.6M → 74.8M (+21.5% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +6.88%2025-06-30 → 2026-06-30$3.24 → $3.46 (+6.9% total)+10.28%2023-06-30 → 2026-06-30$2.58 → $3.46 (+34.1% total)+12.04%2021-06-30 → 2026-06-30$1.96 → $3.46 (+76.5% total)n/a
Book value/share: -5.83%2025-06-30 → 2026-06-30$4.67 → $4.40 (-5.8% total)-18.56%2023-06-30 → 2026-06-30$8.14 → $4.40 (-46.0% total)-14.88%2021-06-30 → 2026-06-30$9.84 → $4.40 (-55.3% total)n/a
Price: +6.46%2025-10-20 → 2026-10-20$21.98 → $23.40 (+6.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+2.11%2023-10-20 → 2026-10-20$21.98 → $23.40 (+6.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-16.01%2021-10-20 → 2026-10-20$55.98 → $23.40 (-58.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +6.46%2025-10-20 → 2026-10-20$21.98 → $23.40 (+6.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+2.11%2023-10-20 → 2026-10-20$21.98 → $23.40 (+6.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-16.01%2021-10-20 → 2026-10-20$55.98 → $23.40 (-58.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -32.0×2020-03 -87.962026-10 -32.22-63.4% over the window
Fwd P/E: -17.3×
P/S (ttm)Market cap ÷ TTM revenue.: 6.8×2020-03 25.272026-10 6.76-73.3% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 5.3×2020-03 7.312026-10 5.32-27.2% over the window
EV/Sales (ttm): 5.6×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -7.44%2019-12 -1.3%2026-06 -10.7%+730.3% over the window
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2019-12 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.8B). Same caveat as the cash buyback yield.: 0.00%2019-12 0.0%2026-06 0.0%

Vs own 10Y history

P/S: 23rd
P/B: 74th

Bar = where today’s multiple sits in SDGR’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+1.21%

-9.62%

-19.37%

+56.00%

YTD

+30.87%

+6.46%

-58.20%

Financial statements

Open full SDGR financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

SDGR — Schrodinger Inc. price, chart and key statistics